Fractyl Health, Inc.
GUTS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001572616
In the last 90 days, Fractyl Health, Inc. insiders filed 1 open-market purchase and 0 sales; 77 institutions reported holding it in 13F filings for Q2 2026, worth $56.2M in total; Maverick Capital is the only superinvestor holding it.
Holders of 5% or more of GUTS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Fractyl Health, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BVP VII Special Opportunity Fund LP | 13G | 9.90%4.77M shares | New | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Fractyl Health, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 23, 202511:43 AM ET | BlackRock, Inc. | 13G/A | 3.70%1.79M shares | −1.50 ppfrom 5.20%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20255:10 PM ET | BVP VII Special Opportunity Fund LPand 4 others | 13G | 9.90%4.77M shares | New | Dec 31, 2024 | SEC |
| Feb 4, 20253:45 PM ET | BlackRock, Inc. | 13G | 5.20%2.48M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Fractyl Health, Inc. shares.
No Form 144 notices for Fractyl Health, Inc. are on file.